To elucidate the role of Tβ10 in human ovarian cancer, we established a new physiological model by co-culturing primary ovarian cancer cells with normal fibroblasts and using a cancer-specific gene delivery system comprising a genetically modified adenovirus. This evidence concerns the gene TMSB10 and ovarian carcinoma.